

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.06285104 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.91207720 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.91207720 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.81268923 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.81268923 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.59469617 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.30861902 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.30861902 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.30861902 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.17223717 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.06732895 |
| 12 | protein carboxylation (GO:0018214) | 5.04171242 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04171242 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.02452665 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.01918167 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 4.97730700 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.95416745 |
| 18 | reverse cholesterol transport (GO:0043691) | 4.78429459 |
| 19 | NADH metabolic process (GO:0006734) | 4.78310936 |
| 20 | angiotensin maturation (GO:0002003) | 4.74594140 |
| 21 | phospholipid efflux (GO:0033700) | 4.74466002 |
| 22 | ethanol oxidation (GO:0006069) | 4.73845471 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.70685710 |
| 24 | urea cycle (GO:0000050) | 4.67116636 |
| 25 | urea metabolic process (GO:0019627) | 4.67116636 |
| 26 | bile acid biosynthetic process (GO:0006699) | 4.66328402 |
| 27 | cysteine metabolic process (GO:0006534) | 4.65619542 |
| 28 | intestinal absorption (GO:0050892) | 4.65385312 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.64076167 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.59362553 |
| 31 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.54132724 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.53882489 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.53644758 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.53644758 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.53644758 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 4.51209589 |
| 37 | low-density lipoprotein particle clearance (GO:0034383) | 4.44837988 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.42245951 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.41997230 |
| 40 | diacylglycerol metabolic process (GO:0046339) | 4.41031034 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.40559108 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 4.39422234 |
| 43 | transcytosis (GO:0045056) | 4.38949904 |
| 44 | alpha-linolenic acid metabolic process (GO:0036109) | 4.36726947 |
| 45 | regulation of complement activation (GO:0030449) | 4.35007609 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 4.32208724 |
| 47 | aldehyde catabolic process (GO:0046185) | 4.18881387 |
| 48 | cholesterol efflux (GO:0033344) | 4.14699415 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.10208143 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.10065581 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.10065581 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.10000168 |
| 53 | lysine metabolic process (GO:0006553) | 4.05455396 |
| 54 | lysine catabolic process (GO:0006554) | 4.05455396 |
| 55 | homocysteine metabolic process (GO:0050667) | 4.03447715 |
| 56 | fructose metabolic process (GO:0006000) | 4.02919545 |
| 57 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.96214530 |
| 58 | bile acid metabolic process (GO:0008206) | 3.96121885 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 3.94502332 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.92096401 |
| 61 | triglyceride homeostasis (GO:0070328) | 3.92096401 |
| 62 | triglyceride catabolic process (GO:0019433) | 3.90129926 |
| 63 | neutral lipid catabolic process (GO:0046461) | 3.88522871 |
| 64 | acylglycerol catabolic process (GO:0046464) | 3.88522871 |
| 65 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87461579 |
| 66 | lipoprotein transport (GO:0042953) | 3.84005366 |
| 67 | amine catabolic process (GO:0009310) | 3.83835197 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 3.83835197 |
| 69 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78825256 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.75949743 |
| 71 | glycine metabolic process (GO:0006544) | 3.74576163 |
| 72 | ethanol metabolic process (GO:0006067) | 3.73051700 |
| 73 | drug metabolic process (GO:0017144) | 3.72854788 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 3.71397421 |
| 75 | fibrinolysis (GO:0042730) | 3.69557515 |
| 76 | phospholipid homeostasis (GO:0055091) | 3.68984515 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65256603 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65256603 |
| 79 | indolalkylamine metabolic process (GO:0006586) | 3.61930657 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.61701377 |
| 81 | tyrosine metabolic process (GO:0006570) | 3.61123104 |
| 82 | protein-lipid complex assembly (GO:0065005) | 3.60787248 |
| 83 | plasma lipoprotein particle organization (GO:0071827) | 3.60197960 |
| 84 | urate metabolic process (GO:0046415) | 3.57854144 |
| 85 | cellular glucuronidation (GO:0052695) | 3.55490240 |
| 86 | cofactor catabolic process (GO:0051187) | 3.55112057 |
| 87 | bile acid and bile salt transport (GO:0015721) | 3.51827703 |
| 88 | lipoprotein metabolic process (GO:0042157) | 3.51115283 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.50817145 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.48252652 |
| 91 | arginine metabolic process (GO:0006525) | 3.47272594 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 3.46965441 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44783099 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.44734696 |
| 95 | sterol homeostasis (GO:0055092) | 3.44565995 |
| 96 | protein-lipid complex subunit organization (GO:0071825) | 3.42834645 |
| 97 | drug catabolic process (GO:0042737) | 3.40554121 |
| 98 | protein activation cascade (GO:0072376) | 3.39142090 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.39086927 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.39086927 |
| 101 | L-ascorbic acid metabolic process (GO:0019852) | 3.37266239 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.36131570 |
| 103 | fatty acid homeostasis (GO:0055089) | 3.35404253 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.35320681 |
| 105 | NAD biosynthetic process (GO:0009435) | 3.35267630 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.32070663 |
| 107 | complement activation (GO:0006956) | 3.32051198 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 3.30140421 |
| 109 | exogenous drug catabolic process (GO:0042738) | 3.30127798 |
| 110 | omega-hydroxylase P450 pathway (GO:0097267) | 3.29636331 |
| 111 | acute-phase response (GO:0006953) | 3.28952785 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.27424056 |
| 113 | drug transmembrane transport (GO:0006855) | 3.25701549 |
| 114 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.24579277 |
| 115 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.24579277 |
| 116 | serine family amino acid biosynthetic process (GO:0009070) | 3.21665227 |
| 117 | complement activation, classical pathway (GO:0006958) | 3.21367318 |
| 118 | ketone body metabolic process (GO:1902224) | 3.20163792 |
| 119 | organic acid catabolic process (GO:0016054) | 3.19683356 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 3.19683356 |
| 121 | glutamate metabolic process (GO:0006536) | 3.17571462 |
| 122 | coenzyme catabolic process (GO:0009109) | 3.15748843 |
| 123 | carnitine metabolic process (GO:0009437) | 3.15263489 |
| 124 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.14469523 |
| 125 | negative regulation of protein activation cascade (GO:2000258) | 3.14365202 |
| 126 | fatty acid beta-oxidation (GO:0006635) | 3.14046046 |
| 127 | primary alcohol metabolic process (GO:0034308) | 3.11529837 |
| 128 | oxaloacetate metabolic process (GO:0006107) | 3.07365444 |
| 129 | oligosaccharide catabolic process (GO:0009313) | 3.03898431 |
| 130 | negative regulation of hemostasis (GO:1900047) | 3.03231586 |
| 131 | negative regulation of blood coagulation (GO:0030195) | 3.03231586 |
| 132 | lipid homeostasis (GO:0055088) | 3.01399676 |
| 133 | glycosphingolipid catabolic process (GO:0046479) | 3.01174135 |
| 134 | hormone catabolic process (GO:0042447) | 3.00372217 |
| 135 | polyketide metabolic process (GO:0030638) | 2.98477192 |
| 136 | doxorubicin metabolic process (GO:0044598) | 2.98477192 |
| 137 | daunorubicin metabolic process (GO:0044597) | 2.98477192 |
| 138 | glycerolipid catabolic process (GO:0046503) | 2.97762908 |
| 139 | regulation of sterol transport (GO:0032371) | 2.96646416 |
| 140 | regulation of cholesterol transport (GO:0032374) | 2.96646416 |
| 141 | regulation of lipoprotein metabolic process (GO:0050746) | 2.95879833 |
| 142 | positive regulation of glycolytic process (GO:0045821) | 2.94744294 |
| 143 | regulation of cholesterol storage (GO:0010885) | 2.92183138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.43583789 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.68207453 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.86563261 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.53637831 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.11827955 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71761973 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28994971 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15949679 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.17261553 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07214794 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94317323 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.80587675 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53330497 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22414125 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21689274 |
| 16 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06902472 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89819209 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86791572 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81641981 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80866252 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78832218 |
| 22 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74538078 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69054804 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65960139 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63942232 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59287112 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56237502 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53787799 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50895136 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45799580 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32663888 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29072032 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25014190 |
| 34 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.23941841 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23183998 |
| 36 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17290685 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15883732 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12255510 |
| 39 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12150121 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11190429 |
| 41 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10818115 |
| 42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10154928 |
| 43 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08865881 |
| 44 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07593195 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07509232 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07030530 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06197361 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05190529 |
| 49 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04811400 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04035016 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03976106 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02529903 |
| 53 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02177717 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01742708 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01648544 |
| 56 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01532375 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00510506 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99522232 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98525600 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97366062 |
| 61 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96785388 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95298356 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95059827 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93714143 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93225859 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91460524 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91414251 |
| 68 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91228026 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90494952 |
| 70 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.90257214 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88515088 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88242422 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87206274 |
| 74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87020490 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85681110 |
| 76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.85113375 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.84858590 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84745239 |
| 79 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84422991 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83486700 |
| 81 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80892323 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80813824 |
| 83 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80751651 |
| 84 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80306761 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80162322 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77840442 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77719611 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77154788 |
| 89 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.76860657 |
| 90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76017238 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75798856 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75506715 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.75501659 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75419503 |
| 95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75419503 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74900086 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74715741 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73492329 |
| 99 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.73481261 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73460031 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73358629 |
| 102 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.73212793 |
| 103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73161558 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72253601 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72230003 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72228229 |
| 107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71935030 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.71892724 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71761242 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71740075 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71505595 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71061151 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70430502 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70430502 |
| 115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70390097 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69889060 |
| 117 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.69403730 |
| 118 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68546831 |
| 119 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67751333 |
| 120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.67688208 |
| 121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.67523281 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66277547 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66038767 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65858236 |
| 125 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65756980 |
| 126 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.64535485 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63742053 |
| 128 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.63021555 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63001975 |
| 130 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.61783663 |
| 131 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61592101 |
| 132 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.61122471 |
| 133 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60196102 |
| 134 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60130176 |
| 135 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.59583865 |
| 136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59039134 |
| 137 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.58012548 |
| 138 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57745167 |
| 139 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57014239 |
| 140 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.55687190 |
| 141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.55165987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.45284018 |
| 2 | MP0005360_urolithiasis | 6.30044022 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.88452533 |
| 4 | MP0005365_abnormal_bile_salt | 4.67757187 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.84289095 |
| 6 | MP0009840_abnormal_foam_cell | 3.79330113 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.20377627 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.12932173 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.06822447 |
| 10 | MP0003252_abnormal_bile_duct | 2.94842884 |
| 11 | MP0005332_abnormal_amino_acid | 2.69101661 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.53531202 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.52900635 |
| 14 | MP0003195_calcinosis | 2.41287131 |
| 15 | MP0005083_abnormal_biliary_tract | 2.40351634 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.21512117 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.18599471 |
| 18 | MP0005666_abnormal_adipose_tissue | 2.09948253 |
| 19 | MP0000609_abnormal_liver_physiology | 1.97788528 |
| 20 | MP0003436_decreased_susceptibility_to | 1.83945794 |
| 21 | MP0003186_abnormal_redox_activity | 1.83788474 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.76808534 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.73748825 |
| 24 | MP0003724_increased_susceptibility_to | 1.71596092 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.66813295 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.64024342 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.60986108 |
| 28 | MP0005375_adipose_tissue_phenotype | 1.57229452 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.56856202 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.49106694 |
| 31 | MP0005451_abnormal_body_composition | 1.47714883 |
| 32 | MP0009764_decreased_sensitivity_to | 1.46810722 |
| 33 | MP0006082_CNS_inflammation | 1.45798066 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43662668 |
| 35 | MP0001764_abnormal_homeostasis | 1.42636568 |
| 36 | MP0009115_abnormal_fat_cell | 1.42190459 |
| 37 | MP0003879_abnormal_hair_cell | 1.41858457 |
| 38 | MP0003011_delayed_dark_adaptation | 1.39560104 |
| 39 | MP0008469_abnormal_protein_level | 1.39017600 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.35484761 |
| 41 | MP0009785_altered_susceptibility_to | 1.35067540 |
| 42 | MP0009697_abnormal_copulation | 1.34090287 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.32494205 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.31298130 |
| 45 | MP0005448_abnormal_energy_balance | 1.27479018 |
| 46 | MP0002419_abnormal_innate_immunity | 1.26295218 |
| 47 | MP0002254_reproductive_system_inflammat | 1.25493926 |
| 48 | MP0000604_amyloidosis | 1.24079607 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.17356710 |
| 50 | MP0000598_abnormal_liver_morphology | 1.16476674 |
| 51 | MP0009763_increased_sensitivity_to | 1.16400288 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.14577118 |
| 53 | MP0005670_abnormal_white_adipose | 1.12852877 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.11134932 |
| 55 | MP0001756_abnormal_urination | 1.09698488 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 1.09435814 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.09045961 |
| 58 | MP0005025_abnormal_response_to | 1.08188377 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.07730142 |
| 60 | MP0003868_abnormal_feces_composition | 1.06279504 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.05425457 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.04872812 |
| 63 | MP0002136_abnormal_kidney_physiology | 1.02321263 |
| 64 | MP0002970_abnormal_white_adipose | 1.01936837 |
| 65 | MP0001845_abnormal_inflammatory_respons | 0.96487833 |
| 66 | MP0004043_abnormal_pH_regulation | 0.96143113 |
| 67 | MP0003122_maternal_imprinting | 0.95561051 |
| 68 | MP0001661_extended_life_span | 0.92403063 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 0.92360517 |
| 70 | MP0001853_heart_inflammation | 0.92198408 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.91180337 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.90157401 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.89432261 |
| 74 | MP0000343_altered_response_to | 0.88245097 |
| 75 | MP0005000_abnormal_immune_tolerance | 0.87942579 |
| 76 | MP0004883_abnormal_blood_vessel | 0.87279855 |
| 77 | MP0004272_abnormal_basement_membrane | 0.86228910 |
| 78 | MP0005166_decreased_susceptibility_to | 0.83910557 |
| 79 | MP0003953_abnormal_hormone_level | 0.83578181 |
| 80 | MP0003959_abnormal_lean_body | 0.83433340 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 0.83199919 |
| 82 | MP0001765_abnormal_ion_homeostasis | 0.83117395 |
| 83 | MP0003690_abnormal_glial_cell | 0.82249968 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.81636282 |
| 85 | MP0003075_altered_response_to | 0.80080188 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.79918007 |
| 87 | MP0003283_abnormal_digestive_organ | 0.79370100 |
| 88 | MP0005409_darkened_coat_color | 0.79314686 |
| 89 | MP0005164_abnormal_response_to | 0.78196411 |
| 90 | MP0005408_hypopigmentation | 0.77819621 |
| 91 | MP0000249_abnormal_blood_vessel | 0.77717318 |
| 92 | MP0000685_abnormal_immune_system | 0.76618424 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.76112739 |
| 94 | MP0010155_abnormal_intestine_physiology | 0.74926106 |
| 95 | MP0001542_abnormal_bone_strength | 0.74523411 |
| 96 | MP0008004_abnormal_stomach_pH | 0.73923206 |
| 97 | MP0003303_peritoneal_inflammation | 0.71145253 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.71032400 |
| 99 | MP0002723_abnormal_immune_serum | 0.69797578 |
| 100 | MP0002971_abnormal_brown_adipose | 0.69573200 |
| 101 | MP0001790_abnormal_immune_system | 0.68908833 |
| 102 | MP0005387_immune_system_phenotype | 0.68908833 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.68301376 |
| 104 | MP0003718_maternal_effect | 0.67573236 |
| 105 | MP0001800_abnormal_humoral_immune | 0.66142344 |
| 106 | MP0003329_amyloid_beta_deposits | 0.64985478 |
| 107 | MP0002405_respiratory_system_inflammati | 0.64492333 |
| 108 | MP0002132_abnormal_respiratory_system | 0.64361202 |
| 109 | MP0005671_abnormal_response_to | 0.63665881 |
| 110 | MP0002933_joint_inflammation | 0.62712582 |
| 111 | MP0004947_skin_inflammation | 0.62439229 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.61679905 |
| 113 | MP0005395_other_phenotype | 0.61429573 |
| 114 | MP0004130_abnormal_muscle_cell | 0.61100730 |
| 115 | MP0005647_abnormal_sex_gland | 0.61047514 |
| 116 | MP0001944_abnormal_pancreas_morphology | 0.60456485 |
| 117 | MP0001879_abnormal_lymphatic_vessel | 0.59992167 |
| 118 | MP0000462_abnormal_digestive_system | 0.59804102 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.59468279 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.59389762 |
| 121 | MP0005334_abnormal_fat_pad | 0.58792039 |
| 122 | MP0000538_abnormal_urinary_bladder | 0.58086698 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.57509005 |
| 124 | MP0005452_abnormal_adipose_tissue | 0.56995915 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.56173147 |
| 126 | MP0002135_abnormal_kidney_morphology | 0.55210101 |
| 127 | MP0008873_increased_physiological_sensi | 0.55100751 |
| 128 | MP0009053_abnormal_anal_canal | 0.55088121 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.54182290 |
| 130 | MP0006054_spinal_hemorrhage | 0.54141727 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.54127843 |
| 132 | MP0005023_abnormal_wound_healing | 0.53203271 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.52924907 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.51986089 |
| 135 | MP0002090_abnormal_vision | 0.51928763 |
| 136 | MP0002896_abnormal_bone_mineralization | 0.51860675 |
| 137 | MP0005535_abnormal_body_temperature | 0.51434396 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.49836703 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.49650044 |
| 140 | MP0004147_increased_porphyrin_level | 0.49187224 |
| 141 | MP0003123_paternal_imprinting | 0.48786435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.58074292 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.56544796 |
| 3 | Xanthomatosis (HP:0000991) | 5.34606849 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.21815707 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.16873293 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.11778079 |
| 7 | Complement deficiency (HP:0004431) | 4.95745603 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.84886074 |
| 9 | Joint hemorrhage (HP:0005261) | 4.77559819 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.77442638 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.21215108 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03572978 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.03152257 |
| 14 | Abnormality of complement system (HP:0005339) | 3.98764232 |
| 15 | Hyperglycinuria (HP:0003108) | 3.96233506 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.87582839 |
| 17 | Hyperglycinemia (HP:0002154) | 3.85586346 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.82928796 |
| 19 | Glomerulonephritis (HP:0000099) | 3.82217179 |
| 20 | Hyperammonemia (HP:0001987) | 3.79662249 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.70782272 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.64820054 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.63730820 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.61022048 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.61022048 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.52182480 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.50322770 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40054026 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.34416330 |
| 30 | Ketosis (HP:0001946) | 3.29788103 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.27770198 |
| 32 | Fat malabsorption (HP:0002630) | 3.23402137 |
| 33 | Epidermoid cyst (HP:0200040) | 3.16075010 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.15685270 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.15120846 |
| 36 | Hypercholesterolemia (HP:0003124) | 2.99389084 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98928091 |
| 38 | Myocardial infarction (HP:0001658) | 2.95580904 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 2.84507037 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.77211573 |
| 41 | Axonal loss (HP:0003447) | 2.75650225 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.75642131 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.75286801 |
| 44 | Gout (HP:0001997) | 2.74164036 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73652692 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.73652692 |
| 47 | Nephritis (HP:0000123) | 2.68502078 |
| 48 | Nausea (HP:0002018) | 2.64009601 |
| 49 | Proximal tubulopathy (HP:0000114) | 2.63967051 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.62284052 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.62284052 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.62284052 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60182764 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.60182764 |
| 55 | Vascular calcification (HP:0004934) | 2.57247516 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56449285 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56449285 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56449285 |
| 59 | Facial shape deformation (HP:0011334) | 2.54525076 |
| 60 | Potter facies (HP:0002009) | 2.54525076 |
| 61 | Steatorrhea (HP:0002570) | 2.53030598 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.52455409 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.50184874 |
| 64 | Recurrent bacterial skin infections (HP:0005406) | 2.49395540 |
| 65 | Ileus (HP:0002595) | 2.49274047 |
| 66 | Metabolic acidosis (HP:0001942) | 2.49264226 |
| 67 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.48187634 |
| 68 | Conjugated hyperbilirubinemia (HP:0002908) | 2.47174914 |
| 69 | Ketoacidosis (HP:0001993) | 2.45241703 |
| 70 | Symptomatic seizures (HP:0011145) | 2.44719854 |
| 71 | Lethargy (HP:0001254) | 2.42984119 |
| 72 | Abnormality of vitamin metabolism (HP:0100508) | 2.42593057 |
| 73 | Delayed CNS myelination (HP:0002188) | 2.41721487 |
| 74 | Retinal atrophy (HP:0001105) | 2.40527790 |
| 75 | Abnormality of magnesium homeostasis (HP:0004921) | 2.36850405 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.35176808 |
| 77 | Esophageal varix (HP:0002040) | 2.33814687 |
| 78 | Pigmentary retinal degeneration (HP:0001146) | 2.33350181 |
| 79 | Menorrhagia (HP:0000132) | 2.33083111 |
| 80 | Spontaneous abortion (HP:0005268) | 2.31536410 |
| 81 | Nuclear cataract (HP:0100018) | 2.28723233 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.26742753 |
| 83 | Hypophosphatemia (HP:0002148) | 2.26479163 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.26409322 |
| 85 | Widely patent fontanelles and sutures (HP:0004492) | 2.22192676 |
| 86 | Malnutrition (HP:0004395) | 2.21394277 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.20708027 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.20708027 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.20690678 |
| 90 | Glycosuria (HP:0003076) | 2.20690678 |
| 91 | Pancreatitis (HP:0001733) | 2.19990587 |
| 92 | Hyperactive renin-angiotensin system (HP:0000841) | 2.17095937 |
| 93 | Gingival bleeding (HP:0000225) | 2.15238665 |
| 94 | Metabolic alkalosis (HP:0200114) | 2.14336647 |
| 95 | Hyperuricemia (HP:0002149) | 2.13732743 |
| 96 | Increased purine levels (HP:0004368) | 2.13732743 |
| 97 | Skin nodule (HP:0200036) | 2.12160882 |
| 98 | Acanthocytosis (HP:0001927) | 2.11824708 |
| 99 | Recurrent abscess formation (HP:0002722) | 2.10900375 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.09056236 |
| 101 | Amyloidosis (HP:0011034) | 2.08287759 |
| 102 | Vomiting (HP:0002013) | 2.06528664 |
| 103 | Insulin resistance (HP:0000855) | 2.06403869 |
| 104 | Abnormality of renin-angiotensin system (HP:0000847) | 2.06321908 |
| 105 | Irritability (HP:0000737) | 2.06112712 |
| 106 | Hyperglycemia (HP:0003074) | 2.05883263 |
| 107 | Increased circulating renin level (HP:0000848) | 2.04773844 |
| 108 | Abnormal urine phosphate concentration (HP:0012599) | 2.03891174 |
| 109 | Hypomagnesemia (HP:0002917) | 2.03680317 |
| 110 | Abnormal cartilage morphology (HP:0002763) | 2.03254919 |
| 111 | Hypotension (HP:0002615) | 2.02768889 |
| 112 | Thrombophlebitis (HP:0004418) | 2.02256393 |
| 113 | Hypophosphatemic rickets (HP:0004912) | 1.98703364 |
| 114 | Prolonged neonatal jaundice (HP:0006579) | 1.96290297 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 1.95251056 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 1.94979269 |
| 117 | Abnormality of carpal bone ossification (HP:0006257) | 1.94079663 |
| 118 | Cerebral edema (HP:0002181) | 1.93406633 |
| 119 | Abnormality of macrophages (HP:0004311) | 1.93138005 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92575775 |
| 121 | Alkalosis (HP:0001948) | 1.92471295 |
| 122 | Late onset (HP:0003584) | 1.90841873 |
| 123 | Abnormal tarsal ossification (HP:0008369) | 1.90717936 |
| 124 | Autoimmune thrombocytopenia (HP:0001973) | 1.90225936 |
| 125 | Acanthosis nigricans (HP:0000956) | 1.89802388 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89423232 |
| 127 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.88629681 |
| 128 | Upper motor neuron abnormality (HP:0002127) | 1.86803137 |
| 129 | Hypoglycemic seizures (HP:0002173) | 1.86548576 |
| 130 | Rickets (HP:0002748) | 1.85541140 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.84052346 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.81019703 |
| 133 | Purpura (HP:0000979) | 1.80407797 |
| 134 | Mitral stenosis (HP:0001718) | 1.79656651 |
| 135 | Renal cortical cysts (HP:0000803) | 1.77208901 |
| 136 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77036179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.50777343 |
| 2 | RIPK1 | 3.62831975 |
| 3 | ERN1 | 3.50743111 |
| 4 | BLK | 3.04792869 |
| 5 | FGFR4 | 2.79580008 |
| 6 | IRAK3 | 2.75358730 |
| 7 | NEK9 | 2.65188685 |
| 8 | TYK2 | 2.60664633 |
| 9 | KDR | 2.56284497 |
| 10 | NME2 | 2.50491484 |
| 11 | FGFR3 | 2.45642465 |
| 12 | MST1R | 2.39809345 |
| 13 | TGFBR2 | 2.38373207 |
| 14 | DDR2 | 2.38117098 |
| 15 | LMTK2 | 2.23874614 |
| 16 | MAP3K14 | 2.18968282 |
| 17 | MAP3K2 | 2.09997673 |
| 18 | TAOK3 | 2.04148945 |
| 19 | ABL2 | 1.97322778 |
| 20 | TBK1 | 1.94273864 |
| 21 | MAPKAPK3 | 1.91288835 |
| 22 | SIK1 | 1.91155006 |
| 23 | MAP3K12 | 1.90979045 |
| 24 | MAP2K3 | 1.88699997 |
| 25 | PIK3CG | 1.88615788 |
| 26 | PBK | 1.87423847 |
| 27 | TIE1 | 1.67811280 |
| 28 | MAP3K11 | 1.65482085 |
| 29 | TRIB3 | 1.51908217 |
| 30 | STK16 | 1.46850033 |
| 31 | IRAK4 | 1.45217730 |
| 32 | PIM2 | 1.44894236 |
| 33 | PDPK1 | 1.41898591 |
| 34 | JAK1 | 1.35913534 |
| 35 | MAP3K3 | 1.35483459 |
| 36 | OXSR1 | 1.34108910 |
| 37 | MAP3K1 | 1.31639515 |
| 38 | FGFR2 | 1.30701530 |
| 39 | WNK4 | 1.29773559 |
| 40 | IKBKB | 1.25037105 |
| 41 | EEF2K | 1.24341693 |
| 42 | NLK | 1.22769902 |
| 43 | PDGFRA | 1.21746658 |
| 44 | EIF2AK1 | 1.17829035 |
| 45 | STK39 | 1.15968830 |
| 46 | MET | 1.14005473 |
| 47 | ZAP70 | 1.13873305 |
| 48 | IKBKE | 1.13824767 |
| 49 | MAPK11 | 1.11824124 |
| 50 | JAK2 | 1.11403234 |
| 51 | PKN2 | 1.07566983 |
| 52 | PDK2 | 1.06448959 |
| 53 | PRKACG | 1.04211455 |
| 54 | GRK7 | 1.01256511 |
| 55 | CDC42BPA | 0.98811209 |
| 56 | EPHA2 | 0.96936153 |
| 57 | STK38L | 0.95523929 |
| 58 | EPHB1 | 0.93338084 |
| 59 | MAP4K1 | 0.93192046 |
| 60 | PTK6 | 0.92358253 |
| 61 | RPS6KA4 | 0.91551893 |
| 62 | ERBB4 | 0.91477122 |
| 63 | INSRR | 0.90675772 |
| 64 | STK10 | 0.89905297 |
| 65 | CSK | 0.89624263 |
| 66 | FRK | 0.89133687 |
| 67 | BTK | 0.88943719 |
| 68 | EPHB2 | 0.88367486 |
| 69 | FER | 0.88058055 |
| 70 | PRKAA1 | 0.84910895 |
| 71 | BMX | 0.82758107 |
| 72 | PDK1 | 0.80254769 |
| 73 | ICK | 0.77025298 |
| 74 | TXK | 0.76639851 |
| 75 | TEC | 0.75591433 |
| 76 | NUAK1 | 0.75433578 |
| 77 | KIT | 0.73887392 |
| 78 | RIPK4 | 0.73358187 |
| 79 | MAP2K6 | 0.72968572 |
| 80 | PAK4 | 0.72728519 |
| 81 | MAP2K2 | 0.72476432 |
| 82 | LYN | 0.72002999 |
| 83 | CAMKK2 | 0.71327285 |
| 84 | CSF1R | 0.71191928 |
| 85 | DAPK2 | 0.71100558 |
| 86 | MST4 | 0.69489205 |
| 87 | TAOK2 | 0.68607621 |
| 88 | CDK6 | 0.67542342 |
| 89 | FLT3 | 0.66928243 |
| 90 | GRK1 | 0.66511218 |
| 91 | PIM1 | 0.66050672 |
| 92 | TGFBR1 | 0.65168018 |
| 93 | AKT3 | 0.64304060 |
| 94 | STK24 | 0.63280430 |
| 95 | LATS2 | 0.62844312 |
| 96 | LRRK2 | 0.62469693 |
| 97 | ACVR1B | 0.62099675 |
| 98 | LATS1 | 0.61889278 |
| 99 | RET | 0.61504255 |
| 100 | JAK3 | 0.60237740 |
| 101 | MATK | 0.59801317 |
| 102 | MOS | 0.58114983 |
| 103 | PRKG2 | 0.57494368 |
| 104 | TRPM7 | 0.56302242 |
| 105 | CHUK | 0.55082513 |
| 106 | DMPK | 0.54037779 |
| 107 | MYLK | 0.53353193 |
| 108 | SRC | 0.51827632 |
| 109 | TAOK1 | 0.51651293 |
| 110 | WNK3 | 0.51503354 |
| 111 | MAPK12 | 0.51129039 |
| 112 | PRKG1 | 0.49399991 |
| 113 | FGR | 0.48690527 |
| 114 | EIF2AK2 | 0.47422260 |
| 115 | PRKAA2 | 0.47060814 |
| 116 | SGK494 | 0.46915273 |
| 117 | SGK223 | 0.46915273 |
| 118 | PRKCZ | 0.46609074 |
| 119 | PRKCD | 0.46431240 |
| 120 | CAMK1D | 0.46301922 |
| 121 | YES1 | 0.45703691 |
| 122 | TESK1 | 0.45473145 |
| 123 | MAP2K1 | 0.44664224 |
| 124 | MAP3K5 | 0.44635035 |
| 125 | EGFR | 0.43939941 |
| 126 | ARAF | 0.43694505 |
| 127 | IRAK1 | 0.42606367 |
| 128 | IGF1R | 0.41831756 |
| 129 | HCK | 0.41672447 |
| 130 | GRK6 | 0.41341092 |
| 131 | PRKCA | 0.40525721 |
| 132 | DYRK1B | 0.38734151 |
| 133 | MAPK4 | 0.38050100 |
| 134 | PRPF4B | 0.37894413 |
| 135 | EPHA3 | 0.37504473 |
| 136 | GSK3A | 0.37107727 |
| 137 | MAP3K13 | 0.36944674 |
| 138 | CAMK2D | 0.36373670 |
| 139 | PTK2 | 0.36266374 |
| 140 | TESK2 | 0.36199141 |
| 141 | PIK3CA | 0.35431109 |
| 142 | ERBB2 | 0.34697014 |
| 143 | ABL1 | 0.34502312 |
| 144 | NTRK3 | 0.34313734 |
| 145 | PRKACA | 0.34124449 |
| 146 | SYK | 0.34070088 |
| 147 | AKT2 | 0.29222356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.94632191 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24840849 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.05993870 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85093084 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77131057 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73115614 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68567239 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62435509 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.60777305 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46538232 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41533849 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34324706 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28041108 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.19038582 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.13034439 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00324063 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93895613 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86154779 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84840204 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84264179 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82637071 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75605660 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72381528 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67687662 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60280399 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59073031 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57695738 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55587458 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51419468 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50100832 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.48077960 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43906993 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43827647 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43737314 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37459489 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35682212 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31653593 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30620265 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27496906 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.24050694 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22112912 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14263544 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12529279 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12382182 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11926849 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11676496 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10439730 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08732364 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05648977 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03213895 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02821251 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02326700 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99978369 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99230032 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.98140291 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95272697 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79647150 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79058212 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77778079 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77670205 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.70302446 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67321025 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67148299 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64472033 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64391885 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62562478 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62544845 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61667302 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60195246 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57913971 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55747713 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54512104 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53780717 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52259728 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.49823781 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48711162 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46854761 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43703282 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41027041 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.40663124 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37958426 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37404330 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.36526000 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35531512 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33123419 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28442857 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28098796 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28084286 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27977415 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27759109 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.26081542 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.26073652 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25906991 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25170297 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24372103 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.22419014 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20352160 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19913725 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.19279119 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.19226060 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19169856 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16256800 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15567481 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14937487 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.13988478 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.11770492 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.11672858 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.11371539 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.11337158 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10665888 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10519706 |
| 112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.09097177 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.08020879 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.07477555 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.07292882 |
| 116 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.07100004 |
| 117 | Proteasome_Homo sapiens_hsa03050 | 0.06696012 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06441662 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.06120273 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.04275752 |

